NCT01214980

Brief Summary

Subjects requiring skin grafting due to burns, trauma, or chronic venous ulcers with split thickness donor sites expected to be between 20 and 200 square cm will be consecutively screened for study eligibility. This study is a prospective, randomized, controlled trial evaluating effect of MIST Therapy on the healing of split thickness skin graft donor sites compared to standard care. Subjects meeting all eligibility criteria and providing appropriate written informed consent will be enrolled for study participation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 5, 2010

Completed
1.3 years until next milestone

Study Start

First participant enrolled

February 1, 2012

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
6 months until next milestone

Results Posted

Study results publicly available

December 19, 2014

Completed
Last Updated

December 19, 2014

Status Verified

December 1, 2014

Enrollment Period

1.4 years

First QC Date

October 4, 2010

Results QC Date

December 11, 2014

Last Update Submit

December 18, 2014

Conditions

Keywords

Low-frequency ultrasoundWound healingSplit thickness wound healingSkin graft donor site healing

Outcome Measures

Primary Outcomes (1)

  • Rate of Wound Healing

    The primary endpoint is an average of the group for each participant's donor site wound closure time, defined as days to absence of drainage from the date of the initial donor site harvest procedure.

    Days to absence of drainage from the initial donor site harvest procedure

Secondary Outcomes (4)

  • Time to Full Epithelialization

    Days to full epithelialization

  • Numeric Pain Score

    5 weeks

  • Numeric Itching Score

    5 weeks

  • Donor Site Recidivism Rate

    6 weeks

Study Arms (2)

MIST Therapy in conjunction with SOC

EXPERIMENTAL

Low-frequency, non-contact ultrasound administered in conjunction with standard of care treatment

Device: MIST Therapy

Control arm

ACTIVE COMPARATOR

Standard of care treatment

Other: Standard of care

Interventions

Low-frequency, non-contact ultrasound therapy provided in conjunction with standard of care treatment on a daily basis for 5 days.

Also known as: MIST, MIST Treatment
MIST Therapy in conjunction with SOC

Standard of care provided per site-specific protocol

Also known as: Standard wound care
Control arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female subject of any race and at least 18 years old
  • Subject requires skin grafting
  • Subject's wound must be between 20 cm2 and 200 cm2
  • Subject's wound presents with no clinical signs of acute infection
  • Subject has ahd no prior MIST Therapy to the enrolled wound
  • Subject or subject's legally authorized representative understands the nature of the procedure(s) and provides written informed consent prior to study enrollment
  • Subject is willing and able to comply with all specified care and visit requirements
  • Women of childbearing potential must not be pregnant or lactating, and must be using adequate and accepted contraceptive methods
  • Subject has a reasonable expectation of completing the study

You may not qualify if:

  • Subject's condition requires the use of topical antibiotics at the time of study enrollment
  • Subject's wound would require ultrasound near an electronic implant or prosthesis, e.g., near or over the heart, or over the thoracic area if the subject is using a cardiac pacemaker
  • Subject is known to be suffering from a disorder or other situation that the subject or investigator feels would interfere with compliance or other study requirements
  • Subject is currently enrolled or has been enrolled in the last 30 days in another investigational device or drug trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tampa General Hospital

Tampa, Florida, 33606, United States

Location

Related Publications (2)

  • Sinha S, Gabriel VA, Arora RK, Shin W, Scott J, Bharadia SK, Verly M, Rahmani WM, Nickerson DA, Fraulin FO, Chatterjee P, Ahuja RB, Biernaskie JA. Interventions for postburn pruritus. Cochrane Database Syst Rev. 2024 Jun 5;6(6):CD013468. doi: 10.1002/14651858.CD013468.pub2.

  • Prather JL, Tummel EK, Patel AB, Smith DJ, Gould LJ. Prospective Randomized Controlled Trial Comparing the Effects of Noncontact Low-Frequency Ultrasound with Standard Care in Healing Split-Thickness Donor Sites. J Am Coll Surg. 2015 Aug;221(2):309-18. doi: 10.1016/j.jamcollsurg.2015.02.031. Epub 2015 Mar 14.

MeSH Terms

Conditions

BurnsWounds and InjuriesVaricose Ulcer

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Varicose VeinsVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Limitations and Caveats

Participants were not blinded to study treatment.

Results Point of Contact

Title
Dr. Lisa Gould
Organization
University South Florida

Study Officials

  • Lisa J Gould, M.D.,Ph.D

    James A. Haley Veterans Hospital

    PRINCIPAL INVESTIGATOR
  • David Smith, MD

    University South Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2010

First Posted

October 5, 2010

Study Start

February 1, 2012

Primary Completion

July 1, 2013

Study Completion

July 1, 2014

Last Updated

December 19, 2014

Results First Posted

December 19, 2014

Record last verified: 2014-12

Locations